(From tke Serological Laboratory of the Off~.e of tke Chief Medir.a~ Examiner of the City of New York)
(Received for publication, June 6, 1947) For a long time no satisfactory explanation could be found for the observation that many Rh-negative patients with clinical evidence of Rh sensitization had no demonstrable Rh antibodies in their sera. Recent work (1, 2) has shown that the reason for the apparent absence of Rh antibodies from the sera of such patients is that individuals sensitized to any antigen may form either or both of two major varieties of specific antibodies, namely, agglutinins (bivalent antibodies) and blocking antibodies or glutinins (univalent antibodies). Rh blocking antibodies are characterized by their inability to clump Rh-positive red ceils in saline media, though they are specifically adsorbed by such cells and render the cells inagglutinable by subsequently added specific anti-Rh agglutinating sera. According to Wiener (3, 4) plasma (and serum) contains a substance called conglutinin, apparently a colloidal aggregate of plasma proteins and probably identical with the so Called X-protein, which is adsorbed by red cells after they have been specifically sensitized by univalent antibodies, thus causing them to stick together (conglutination).
Briefly, therefore, serological clumping may be brought about by two distinct mechanisms, agglutination and conglutination, which have the following distinguishing features. Agglutination occurs in saline media and is not improved by the presence of plasma or serum; according to the present authors' views this reaction takes place in a single stage through the action of bivalent (or multivalent) antibodies which "rink" the multivalent red cells together. Conglutination, on the other hand, occurs only in the presence of plasma or serum or other media containing conglutinin. This reaction takes place in two stages: first the specific combination between red cells and the corresponding univalent antibodies, and then adsorption of the non-specific conglutinin by the sensitized red cells causing the cells to "stick" together. Thus, conglutinin plays an analogous rSle in the conglutination reaction to that of complement in serological hemolysis. Evidence has been obtained that individuaks sensitized to the A and B factors can similarly form these two varieties of specific antibodies 267 (5, 6) and there is no reason to doubt the general immunological significance d the phenomenon (7) .
From the foregoing it seems apparent that the intensity of the clumping in the conglutination test will depend not only on the titer of blocking antibody (or giutinin) but also on the quantity and quality of the conglutinin. The use of a potent conglutinin should increase the sensitivity of the conglutination test in much the same way that a potent complement reduces the amount of sheep cell amboceptor required to cause specific hemolysis of sheep erythrocytes. It therefore seemed worth while to investigate what factors influence the quality of conglutinin, and the purpose of this paper is to present the resuits of some of these experiments.
Materials and Methods
To facilitate the comparison of results obtained on different days the Rh antisera used in the inves~gations to be described were obtained from only two individuals. Neither of the sera was capable of dumping Rh-posltlve red eel/sin saline media but strong dumping occurred in the presence of plasma. All the tests were done by the congJutination technic, that is, by fitrstions carried out in the following way (4) . A series of progressively doubled saline dilutions of the Rh antiserum was first accurately prepared, and one drop of each dilution was transferred to a corresponding series of empty tubes (inside diameter 7 ram.). To each tube was then added a drop of a fresh 2 per cent saline suspension of Rh-pesitive red blood cells, and the rack containing the tubes was shaken and placed in a water bath at body temperature. After | hour the tubes were centrifuged at low speed and the supernatant fluid removed as completely as po$~ble with the aid of a fine capillary pipette. (It is important that this step be carefully done because the presence of any residual fluid vitiates the results.) One drop of the so]utlon being tested for its conglutinin content was then added to each tube. The red cells were resuspended by vigorously shaking the tubes and the mixtures incubated for another hour in the water bath. The sediments at the bottom of ea~ tube were then dislodged by gently sh~klng the tubes, though more vigorously than in the case of Rh agglutination tests, and the reactions were read microscopically by placing the tubes on the stage of a microscope under the low power objective.
For those unfamiliar with the conglutination technic it may be mentioned that mistakes in reading the reactions can be avoided if the following points are borne in mind:
In contrast to the reading in the agglutination test, the naked eye reading of the I~ttem of the sediment is of no value in the conglutination test, because in the presence of concentrated plasma negatively reacting bloods do not give the typical negative sediment reading. One must rely entirely on the microscopic reading. Also cen~tion does not improve the reactions and should be avoided. In the presence of plasma, centrifugation tends to pack the cells together into rounded masses, and when the tubes are subjected to the same amount of shaking as is necessary to render the negative control homogenous, weak reactions may be destroyed. Accordingly, for the conglutination test sedimentation is preferable to centrifugstion.
The plasma used in the experiments was obtained by collecting blood in tubes containing dried oxaiate powder, prepared as for the Wintrobe-Landsherg sedimentation test. The tubes were inverted several times until the powder was completely dissolved and the plasma was separated either by sedimentation or by centrifugafion. To obtain serum, blood was collected in dry clean tubes and allowed to clot. The clots were rimmed and the serum was ~srated either by centrifugation or by allowing the Clots to retract. The selxlm and plalms were usually used fresh, or stored in the refrigerator for not longer #hArt 2 or 3 dsys.
The 25 per cent human albumin solution used in the experiments was purchased from the Cutter Laboratories; the 30 per cent bovine albumin solution from Armour and Company. The concentrated immune human gamma globulin used in our experiments was the preparation distributed by Cutter Laboratories for measles and pertussls prophylaxis.
All titrations were performed at least in duplicate against Rh-positive group O cells of types Rh~ and Rhs, and control tests with type rh cells were alwsys included. In general, the results were the same regardless of the type of the Rh-positive cells. All of the experi. ments were repeated several times, but in the tables only a few representative protocols will be given.
RESULTS
The experiments to determine the nature of conglutinln will be presented under three headings, namely, (1) studies on oxalated plasma and serum (natural conglutinin), (2) studies on the effect of the addition of purified albumin and globulin to plasma (fortified conglutinin), and (3) studies on purified solutions of albumin and globulin and mixtures of these solutions (synthetic conglutlnin).
Studies on Oxalated Plasma and Serum
Pooled oxalated plasma from a number of normal adults was mixed in different proportions with saline solution in order to determine the effect of dilution on the conglutinating action of plasma. The following series of dilutions were prepared: 9 parts of plasma and 1 part of saline; 8 parts of plasma and 2 parts of saline; 7 parts of plasma and 3 parts of saline, etc., and then the conglutinating activities of these dilutions were compared quantitatively with that of the original plasma. As shown in Table I , the activity progressively diminished as more and more saline was introduced, and no reactions were obtained when the concentration of the plasma was lower than 40 per cent of its original strength. When equal parts of plasma and saline were mixed, the titer obtained was only one-tenth as high as that obtained with the original plasma and the reactions were much less distinct.
This explains why the sera from certain Rh-negative patients with clinical evidence of Rh sensitization, when titrated by the agglutination method, that is, in safine media, often show distinct clumping in the first tube of the titration but little or none in any of the higher dilutions. The clumping observed in the first tube in such cases is not due to agglutination but to conglutination, as can be confirmed by repeating the titration, using the conglutination technic. In the first tube of a titration, the serum being tested is diluted only by the equal volume of the red cell suspension, so that, as shown in Table I , it is still possible for conglutination to occur owing to the action of residual conglutinin in the patient's own serum. These findings also explain the conflicting reports of British (8) and American workers (9, 10) concerning the frequency with which anti-Rh agglutinins can be detected in the sera of sensitized patients. The technic used by the British workers (8) apparently permitted conglutination to occur and hence their reports that almost I00 per cent of sensitized Rhnegative individuals have detectable anti-Rh "agglutinins" in their sera are due to the failure to distinguish between clumping due to agglutination and clumping due to conglutination. American workers on the other hand, found that less than 50 per cent of sensitized patients have anti-Rh agglutinins in their sera, because the technic used by these workers precluded the occurrence of conglutination. Confusion can be avoided if the terms "agglutinin" and "bivalent antibody" are reserved for those antibodies which produce clumping in saline 
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1 0 * The tlter is the reciprocal of the highest dilution gxving a one plus reaction. Where no tube showed a one plus reaction, the titer is estimated by interpolation. media (agglutination) while the terms "blocking antibody," "glutinin," or "univalent antibody" are employed for those antibodies which can produce clumping only in the presence of plasma proteins (conglutination). As an all inclusive term "Rh antibodies" should be used instead of "Rh agglutinins," in order to avoid ambiguity. Similarly, when describing the reactions, "clumping" should be used as the all inclusive term because the use of the term "agglutination" would cause confusion.
The observations shown in Table I are readily explained if, as has been suggested in a previous paper (3), conglutinin is identical with the so called X-protein studied by Pedersen (11) . As Pedersen has pointed out, in dilute solutions plasma and serum behave in the ultracentrifuge as if they contain two major protein components, albumin and gamma globulin. As the dilution is decreased a third component (beta globulin or X-protein) appears which thereafter increases linearly with increase in total protein concentration, at the expense of the albumin and gamma globulin. Pedersen concludes that Xprotein is a reversibly dissociable compound formed by albumin, globulin, and certain lipids, having a total particle weight of about a million. He also believes that X-protein probably contains 3 or 4 times as many molecules of albumin as of globulin. As shown in the diagram in Pedersen's monograph, X-protein was first detectable in the ultracentrifuge when there was a total protein concentration of about 1.5 gin. per 100 cc., while in our experiments the lowest protein concentration to give a positive reaction was about 3 per cent. This indicates that the minimal concentration of X-protein to produce a distinct reaction in the conglutination test is about 8/~ to 1 gin. per 100 cc.
From the nature of X-protein it seems obvious that it would be impossible to obtain X-protein ~ the form of a pure solution. The formation of X-protein can be expressed by the following equilibrium equation:
In view of a recent report by Jakobowicz and Bryce (12) , the experiment shown in Table I was repeated, using cerebrospinal fluid as a diluent instead of saline solution, and identical results were obtained. The phenomenon observed by these authors must therefore be ascribed to the water content and not any special property peculiar to cembrospinal fluid. The bizarre results obtained by them were probably due to the use of sera containing a mixture of agglutinating and blocking antibodies of approximately equal titers. In our hands, such sera gave erratic results in tests performed in saline media. Thus, in some experiments strong clumping was obtained, while in tests made on other days with serum of the same derivation, the clumping was weak or absent, owing to competition between the two sorts of antibodies present in the serum.
In order to determine the effect of heating on conglutinin, samples of pooled plasma and serum were heated for one-half hour at 56°C. in the water bath. The conglutinating activities of the heated and unheated plasma and serum were then compared. As shown in Table II , in accordance with findings previously reported (4), pooled unheated serum is distinctly less active than pooled unheated plasma. Heating improves the activity of serum but weakens the activity of plasma so that the two approximate each other. The deleterious effect on plasma is readily explained because heating causes the fibrinogen to precipitate out and thus converts the plasma to serum. Aside from precipitating fibrinogen, heating at 56°C. does not appear to damage conglutinin, but instead seems to stabilize it, judging from the effect of heating on serum. This would seem to make the use of heated serum for conglutination tests desirable, except that heated serum has a greater tendency to produce rouleaux formation than either fresh serum or fresh plasma.
As has just been pointed out, plasma is much more active than serum as a source of conglutinin. Since the only known substance present in plasma that is lacking from serum is fibrinogen, the increased activity must be attributed to this substance. When one considers the low concentration of fibrinogen as compared with the other plasma proteins it may seem surprising that its presence should cause such a marked increase in the conglutinating activity. This finding will be more acceptable if one considers that fibrinogen in conjunction with other proteins makes up the colloidal complex conglutinin, and that it is the quality and quantity of this conglutinin, not merely the concentration of proteins in solution, which determine the conglutinating activity. In the studies 
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* The heated specimens were kept in a water bath at 56°C. for one-half hour.
of Pedersen discussed above the fibrinogen content of the serum was not taken into account. The conglutinating activities of samples of plasma of different normal individuals and patients were next compared in order to determine whether there are individual variations in the congintinin content of plasma from normal individuals, and whether the conglutinin content is affected by particular diseases. This work is still in progress and can be reported only in a preliminary manner at the present time. No significant difference could be demonstrated in the conglutinin content of plasma from different normal individuals or from the same individual at different times. A small but significant increase in the conglutinating activity was demonstrated in some patients with pneu-monla and other infectious diseases, which is readily understandable in view of the high fibrinogen content of plasma of such patients, as demonstrated also by the high sedimentation rate. That increased fibrinogen was not always the explanation for the increased conglutinin content of plasma was indicated by experiments on the corresponding blood serums in which an increased conglutinin content could also at times be demonstrated. Other important factors to be taken into consideration are the albumin-globulin ratio and the state of hydration of the individual. 
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Comparison of the conglutinin activity of plasma at various ages showed significant differences, particularly during the fetal and neonatal periods (of .  Table III) as compared with adult plasma. It is interesting that the findings obtained in these experiments confirm the prediction made by one of us (3) purely on theoretical grounds. Since blocking antibodies (or glutinins) behave as if they are univalent and agglutinins behave as 'if they are bivalent, it was reasoned that the former are probably comprised of smaller molecules. This ~ idea has been confirmed by demonstrating (13, 14) that blocking antibodies traverse the placenta more readily than agglutinins. To account for the abrupt onset of icterus gravis shortly after birth, it was postulated that the plasma of the fetus in uWro is deficient in conglutinin, but that conglutinin increases in concentration abruptly after birth and is adsorbed by the infant's red blood cells which are already coated with univalent maternal antibody acquired from the mother while in utero. The observations shown in Tables III, IV , and V support this hypothesis. Table ILl demonstrates the greater potency of plasma and serum from adults as compared with plasma and serum from fetuses, when used as a source of conglutinin. When cord plasma or serum is used, not only are the titers considerably lower but the clumping is much less pronounced and more easily broken up by shaking. As has already been mentioned, conglutinin seems to consist of a colloidal complex of plasma proteins probably identical with the so called X-protein. Accordingly, the conglutinin content of serum or plasma would be influenced by the concentration of the plasma proteins. Thus, the weaker conglutinating activity of cord plasma and serum corresponds with the lower concentration of plasma proteins in the fetal blood (15) . Direct evidence supporting our concept of the pathogenesis of erythroblastosis was obtained by studying the conglutinin content of plasma from erythroblastotic infants who were treated by exchange transfusion (17, 18) . When whole citrated blood was transfused, it was found that the totalproteinconcentra-tion in the infant's serum rose from a valueof approximately 5.5 gin. per 100 cc. at the beginning of the transfusion to about 7 gm. per 100 cc. at the end of the transfusion,~ and there was a simultaneous rise in the conglutinin content of the serum. On the other hand, when blood was transfused from which gbout two-fifths of the plasma had been removed and replaced with saline, there was no appreciable change in the total protein or conglutinin content. For example, in Table IV , are shown results of such studies on an infant with severe erythroblastosis (icterus gravis) treated by exchange transfusion at the age of 24 hours. In this case, blood from which part of the plasma hadbeenremovedand 16 J replaced with saline was used for treating the infant, and it will be seen that there was no appreciable change in the conglutinin titer after the transfusion. This infant was very ill when first seen--icterus index 60 units, hemoglobin concentration 8.7 gin. per 100 cc., nystagmus and subconjunctivalhemorrhages, spleen firm with edge three fingers below the costal margin, skin mottled due to hemorrhage and jaundice, mother Rh-negative with an anti-P,h titer of 20 units by the agglutination method and 70 units by albumin-plasma conglutination method (16)--but the infant made a complete recovery after the exchange transfusion. As shown in Table IV , tests done 6 days after the transfusion revealed a marked increase in the conglutinating activity of the infant's phsma, and there seems to be no doubt that the disease would have progressed to a fatal termination under the older method of treatment. This case may be contrasted with another treated early in our series before it was our practice to remove part of the phsma from the donor's blood and replace this with saline solution (16, 17) . As shown in Table V , in the earlier case transfused with whole citrated blood, there was a significant increase in the conglutinating activity after the transfusion, and the disease progressed until the infant died on the 6th day, despite the fact that treatment had been instituted without delay after delivery of the infant by Caesarian section and while the clinical manifestatioas were still mild. On the basis of this case we introduced the practice of removing part of the donor's plasma and replacing it with saline solution. While the evidence provided by Tables IV and V may seem episodic, the satisfactory results we have obtained in a series of fifteen exchange transfusions carried out with blood with part of its plasma replaced by saline solution appear to justify this practice.
Fortification of Conglutinin in Plasma by the Addition oJ Albumin and Globulin
In order to throw further light on the nature of conglutinin, experiments were carried out to determine the effect on the conglutinating activity of plasma of the addition to it of albumin and globulin.
It was first found that the addition of certain optimal quantities of albumin markedly enhanced the activity of the plasma and this in fact led us to the development of a new direct test for Rh sensitization (16) . To demonstrate the fortifying effect of added albumin on the conglutinating activity of plasma a series o~ mixtures of 25 per cent human albumin solution and pooled plasma were prepared in the following proportions: 9 parts of 25 per cent albumin solution and 1 part of pooled plasma, 3 parts albumin solution and 1 part of pooled plasma, equal parts albumin solution and plasma, 1 part albumin solution and 3 parts plasma, etc. (of. Table VI ). The conglutinating activity of each of these mixtures was determined and compared with that of the 25 per cent albumin solution and the pooled plasma. It will be seen that the lowest titer was obtained with the concentrated albumin solution (25 units), while the titer given by the pooled plasma was more than twice as high (64 units). 2 Yet by mixing these two ingredients in the proper proportions, a preparation could be obtained which yielded titers as high as 240 units. The titer values form a smooth curve, the optimal results being obtained with a mixture of 1 part of the albumin solution and 3 parts of plasma.* The fact that a certain quantity of albumin gives optimal results in fortifying plasma in the conglutination test falls in with the concept that the added albumin becomes part of the complex which makes up congintinin or X-protein, and does not accord with Diamond and Denton's (19) suggestion that the activity is determined merely by the protein concentration.
Similar results were obtained in experiments on the fortifying effect of added gamma globulin on the conglutinating activity of plasma. Since the gamma globulin fraction contains antibodies, including the isoagglutinins alpha and beta, the ideal preparation to use would be one made from the plasma of an 
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Rh-positive group AB individual. Unfortunately such a preparation was not available to us and our experiments had to be carried out with purchased immune globulin, 4 which had a protein concentration of about 9.2 gm. per 100 cc. 6 A series of mixtures of this globulin solution with pooled plasma were prepared, just as in the experiment with albumin solution, and each mixture was tested for its conglutinating activity. The globulin solution itself gave very unsatisfactory results in the conglutination test; it was even more viscous and difficult to work with than the albumin solution and gave a titer of only 4 units in comparison to the titer of 48 units given by the pooled plasma. Yet as shown in to plasma served to increase the conglutinating activity of the latter. As in the experiments with albumin solution, the titers obtained yielded a fairly smooth curve, the maximal titer (128 units) being obtained when 1 part of globulin solution was mixed with 3 parts of plasma. The fact that a specific amount of globulin gives the optimal result, while the addition of a greater, or a smaller quantity gives a lower conglutination titer, indicates that the added globulin becomes a part of the X-protein complex, and again proves that the conglutinating activity does not depend merely on total protein concentration. These results suggested that a further increase in the sensitivity of the conglutination test might be achieved with the aid of the gloublin solution. As has already been indicated, a mixture of 4 parts plasma with 1 part of 25 
,+: +4 anfi-Rhlserum (patient R ) per cent albumin solution yields titers about 3 to 4 times as high as those obtained with unmodified pooled plasma. If to such a mixture about one-fourth its volume of the concentrated immune gamma globulin solution is added, a still further increase in activity can be achieved, as evidenced by a twofold increase in the titers obtained in the conglutination test. Unfortunately, however, the globulin preparation which was available has the property of giving some weak non-specific reactions , even with group O cells, presumably owing to the presence of some irregular isoantibodies. These experiments have therefore been discontinued temporarily until a better preparation becomes available. namely one from Rh-positive group AB individuals.
Studies on the Conglutinating A ctivily of Mixtures of Solutions of Albumin and Gamma Globulin
The purpose of the next experiments was to determine whether it is possible to produce conglutinin synthetically by mixing suitable quantities of solutions of purified albumin and gamma globulin. We had available the 25 per cent solution of human albllmirL and immune gamma g l o b u l i n solution used in the t e s t s just described.
In order to determine the rnlnlrnum concentration of pure albumin in solution that exhibited any conglutinating activity the 25 per cent solution was mixed with saline in the following proportions: 9 parts albumin solution and 1 part saline solution, 8 parts albumin and 2 parts saline, 7 parts albumin and 3 parts saline, etc., and the conglutinsting activities of these mixtures were compared with one another and with the original albumin solution, as well as with pooled plasma and serum (of. Table VIII) . 
T A B L E VIII
E~e¢~ of D~tdlon of a 25 Per cent Solution of Human Albumin on Its Conglutina~ing Activity
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It appears that albumin solutions with concentrations less than 12.5 per cent have little or no conglutinating activity. Above 12.5 per cent concentration, the conglutinating activity increases and reaches a maximum at a concentration of about 17.5 per cent, while at still higher concentrations the conglutinating activity again diminishes. I t is possible that the low titers obtained with the more concentrated albumin solutions were due to the great viscosity of such solutions. In any event the maximum titer obtained with any solution of albumin barely reached the titer obtained with pooled plasma. Since pooled plasma on the average has a total protein concentration of about 7 gin. per 100 cc., this again demonstrates that the conglutinating activity does not depend merely upon the total protein content.
Similar results were obtained when the immune globulin solution was diluted with saline solution. As shown in Table IX , on the basis of protein concentration gamma globulin has a much higher conglutinating activity than albumin, because a 2.8 per cent gamma globulin solution (mixture of 3 parts of the glob-ulin solution with 7 parts of saline) was still weakly active (titer 4 units), while as already mentioned, solutions of albumin of less than 12.5 per cent strength are practically inactive. As in the case of the albumin solution, the activity of the globulin solution does not depend merely upon the protein concentration, because there is an optimal concentration above which the conglutinin titer decreases. We obtained the maximum titers with a globulin solution of approximately 7 per cent strength. It seems likely that the decrease in titer with higher concentrations of globulin is due, at least in part, to the marked viscosity of such concentrated solutions. The highest titer (48 units) given by any globulin solution was higher than that of the pooled serum control (24 units) but less than that of the pooled plasma control (64 units).
It will be noted that when the 25 per cent albumin solution was diluted with an equal volume of saline solution it was almost devoid of conglutinating activity and the globulin solution was only weakly active when similarly diluted. Starting with these two dilute solutions, namely, 12.5 per cent albumin solution and 4.6 per cent globulin solution, a series of mixtures were prepared in the following proportions: 27 parts globulin solution and 1 part albumin solution, 9 G and 1 A, 3 G and 1 A, 1 G and 1 A, 1 G and 3 A, 1 Gand 9 A, and 1 G and 27 A, and the conglutinating activity of each of these mixtures was then determined and compared with that of pooled human plasma. As shown in Table X , despite the relative inactivity of the original solutions, mixtures were obtained with high conghtinating activities, even exceeding that of pooled plasma. The titers obtained yielded a relatively smooth curve and the maximum titers were obtained with the mixtures 3 G and 1 A, and 1 G and 1 A. The protein content of each mixture was then calculated in terms of albumin, gamma globulin, and total protein. It wiU be seen that the mixtures which gave the highest conglutination titers had total protein concentrations of 6.6 to 8.6 gin. per 100 cc., which is equalto the protein concentration of normal serum. If, based on the above findings, we assume that the optimal results would be given by a mixture of 2 G and 1 A we find that this would correspond to a total The work of Pedersen and the results presented in this paper show that conglutinin and X-protein are substances which can be titrated and weighed. The main test for a new hypothesis is the ability to predict from it correctly hitherto unknown facts, which can be tested by direct experimentation, and to open new fields of research. As shown in the present paper, the theory of conglutination has led to new, more sensitive tests (16) for univalent antibodies and has resulted in the prediction, now substantiated, that conglutinin can be formed in ~itro by mixing solutions of albumin and gamma globulin in proper proportions. It has also led to a new theory of pathogenesis of erythroblastosis fetalis which is already supported by a considerable body of experimental data (20, 21) . Moreover, these new concepts have increased the accuracy of the prenatal prediction not only of the occurrence of erythroblastosis fetalis, but also of the type and severity of the disease, and has led further to a more rational and successful treatment of the disease by exchange transfusion (17, 18) .
While the albumin test of Diamond and Denton (19) and the anti-globulin test of Coombs et a~. (22) are ingenious, they are less sensitive and entail the use of special materials not available to the average laboratory. These tests have the disadvantage that they entail artifical conditions having no counterpart in ~i~o, and therefore yield little or no insight into the nature of thereactions of univalent antibodies. SUM~kRY 1. Dilution of pooled plasma with more than an equal volume of saline solution destroys its ability to produce congiutination of red cells sensitized by univalent antibody. This can be correlated with Pedersen's work showing that X-protein is readily dissociated by dilution. The observation explains the discrepancy between the reports of British and American workers regarding the incidence of Rh "agglutinins" in the serum of Rh-negative mothers of erythroblastotic babies.
2. Plasma has a higher conglutinating activity than serum as shown by the finding that plasma gives titers on the average more than twice as high as those obtained with serum. The greater activity of plasma would seem due to the presence of fibrinogen which is apparently an important component of the colloidal complex of plasma proteins making up conglutinin.
3. Aside from its action in precipitating fibrinogen, heating at 56°C. for onehalf hour has no harmful effect on conglutinin.
4. Fetal plasma and serum yield much lower conglutination titers than adult plasma and serum, indicating that fetal blood is deficient in conglutinin. After birth, there is generally a marked increase in the conglutinin content of the blood. There is little or no variation in the congiutinin activity of sera from different normal adult individuals.
5. The use of whole citrated blood in exchange transfusion to an erythroblas-totic baby mused an appreciable rise in the total plasma proteins after the transfusion and a corresponding increase in the conglutinating activity. When however, in another instance, two-fifths of the plasma was removed from the donor's blood and replaced with saline, there was no appreciable change in the protein concentration or conglutinin activity of the infant's plasma after the transfusion. 6. The fortification of pooled plasma by mixing 4 parts of it with 1 part of 25 per cent human albumin solution markedly increased its conglutinin content as shown by a fourfold increase in the conglutination titers obtained. Addition of less or more than this optimal amount of albvmin resulted in lower titers. The 25 per cent human albumin solution itself yielded titers only half as high as did unmodified pooled plasma and was difficult to work with because of its high viscosity. Similar results were obtained in experiments with immune globulin solutions and pooled plasma.
7. Albumin solutions of less than 12.5 per cent concentration had little or no conglutinin activity; similarly, immune globulin solutions of less than 4.6 per cent concentration gave only relatively low titers when used as congiutinin. Yet, mixtures of these dilute solutions in certain optimal proportions yielded solutions with conglutinin activities considerably higher than that of pooled plasma. The albumin-globulin ratio in the mirtures giving the best results proved to be approximately the same as the albumin-globulin ratio of normal human serum or plasma.
8. Suitable mixtures of albumin and globulin solutions with a total protein concentration equal to that of normal plasma gave conglutination titers about four times as high as those obtained with unmodified pooled plasma. This suggests that there may be substances in normal plasma which tend to maintain the albumin and globulin in molecular dispersion. Another possibility is that in the fractionation process the albumin and globulin are rendered less hydrophilic, thus increasing their tendency to form colloidal aggregates. 9. The experiments described support the theory that clumping of cells by univalent antibodies in plasma media occurs in two stages, namely, (1) specific adsorption of univalent antibodies, and (2) non-specific adsorption of congiutinin by the sensitized ceils causing them to stick together. The experiments further support the concept of conglutinin or X-protein as a colloidal aggregate of plasma proteins. Finally, they demonstrate that the intensity of the clumping (conglutination--not agglutination) depends on the quantity and quality of conglutinin and not merely on the total protein content of the medium of suspension.
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